New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Scientists find that microRNA affects inflammation in lupus disease.

Scientists find that microRNA affects inflammation in lupus disease.

by Nagoya UniversityConservation trends of miR-128 and miR-148a target sites with “conserved overlap.” A, B Cumulative distribution of the number of species in which the indicated site types of m
inflammatory disease February 19,2024
Scientists find that microRNA affects inflammation in lupus disease.

Scientists find that microRNA affects inflammation in lupus disease.

by Nagoya UniversityConservation trends of miR-128 and miR-148a target sites with “conserved overlap.” A, B Cumulative distribution of the number of species in which the indicated site types of m
inflammatory disease February 19,2024
Scientists identify a new therapeutic target in macrophages for the treatment of obesity-related diseases

Scientists identify a new therapeutic target in macrophages for the treatment of obesity-related diseases

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Electron microscopy images of lung macrophages in a normal mouse (left) and in a mouse deficient for mitochondrial oxidative p
inflammatory disease February 19,2024
Scientists identify a new therapeutic target in macrophages for the treatment of obesity-related diseases

Scientists identify a new therapeutic target in macrophages for the treatment of obesity-related diseases

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Electron microscopy images of lung macrophages in a normal mouse (left) and in a mouse deficient for mitochondrial oxidative p
inflammatory disease February 19,2024
Single-cell analysis of Crohn's disease reveals a detailed picture of inflammation in the gut

Single-cell analysis of Crohn's disease reveals a detailed picture of inflammation in the gut

by Allessandra DiCorato,Broad Institute of MIT and HarvardGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.01.002Researchers at the Broad Institute of MIT and Ha
inflammatory disease February 19,2024
Single-cell analysis of Crohn's disease reveals a detailed picture of inflammation in the gut

Single-cell analysis of Crohn's disease reveals a detailed picture of inflammation in the gut

by Allessandra DiCorato,Broad Institute of MIT and HarvardGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.01.002Researchers at the Broad Institute of MIT and Ha
inflammatory disease February 19,2024
Researchers discover new autoinflammatory disease, suggest target for potential treatments

Researchers discover new autoinflammatory disease, suggest target for potential treatments

by NIH/National Institute of Allergy and Infectious DiseasesDiscovery of de novo GOF mutations inLYNas cause of cutaneous vasculitis and liver fibrosis syndrome.aThe pedig
inflammatory disease February 19,2024
Researchers discover new autoinflammatory disease, suggest target for potential treatments

Researchers discover new autoinflammatory disease, suggest target for potential treatments

by NIH/National Institute of Allergy and Infectious DiseasesDiscovery of de novo GOF mutations inLYNas cause of cutaneous vasculitis and liver fibrosis syndrome.aThe pedig
inflammatory disease February 19,2024
Nerve–immune cell interactions in the lungs may drive the development of allergic asthma

Nerve–immune cell interactions in the lungs may drive the development of allergic asthma

by Noah Brown,Massachusetts General HospitalGraphical abstract. Credit:Journal of Allergy & Clinical Immunology(2023). DOI: 10.1016/j.jaci.2023.02.011. https://www.jacionline.org
inflammatory disease February 19,2024
Nerve–immune cell interactions in the lungs may drive the development of allergic asthma

Nerve–immune cell interactions in the lungs may drive the development of allergic asthma

by Noah Brown,Massachusetts General HospitalGraphical abstract. Credit:Journal of Allergy & Clinical Immunology(2023). DOI: 10.1016/j.jaci.2023.02.011. https://www.jacionline.org
inflammatory disease February 19,2024
Tackling skin inflammation with vitamin D

Tackling skin inflammation with vitamin D

by Melissa Rohman,Northwestern UniversityVitamin D mitigates acute inflammation with durable effects and suppresses markers of NM injury involved in IL-17 signaling pathways. (A) Volcano plot of
inflammatory disease February 19,2024
Tackling skin inflammation with vitamin D

Tackling skin inflammation with vitamin D

by Melissa Rohman,Northwestern UniversityVitamin D mitigates acute inflammation with durable effects and suppresses markers of NM injury involved in IL-17 signaling pathways. (A) Volcano plot of
inflammatory disease February 19,2024
AI model helps atopic dermatitis patients diagnose complications and malignant diseases

AI model helps atopic dermatitis patients diagnose complications and malignant diseases

byTohoku UniversityImages of skin lesions can vary significantly depending on the distance between the lesion and the imaging device. By minimizing the imaging bias caused by distance, the accur
inflammatory disease February 19,2024
AI model helps atopic dermatitis patients diagnose complications and malignant diseases

AI model helps atopic dermatitis patients diagnose complications and malignant diseases

byTohoku UniversityImages of skin lesions can vary significantly depending on the distance between the lesion and the imaging device. By minimizing the imaging bias caused by distance, the accur
inflammatory disease February 19,2024
Leprosy, scabies and yaws: Togo's neglected tropical skin diseases need attention, says study

Leprosy, scabies and yaws: Togo's neglected tropical skin diseases need attention, says study

by Michael Head, Bayaki Saka and Palokinam Pitche,The ConversationLocation of Lomé, capital city of Togo and where the schools were sited, and the rural community of Ndjei. Image drawn within ou
inflammatory disease February 19,2024
Leprosy, scabies and yaws: Togo's neglected tropical skin diseases need attention, says study

Leprosy, scabies and yaws: Togo's neglected tropical skin diseases need attention, says study

by Michael Head, Bayaki Saka and Palokinam Pitche,The ConversationLocation of Lomé, capital city of Togo and where the schools were sited, and the rural community of Ndjei. Image drawn within ou
inflammatory disease February 19,2024
Harnessing good fats to relieve multiple sclerosis symptoms

Harnessing good fats to relieve multiple sclerosis symptoms

by American Society for Biochemistry and Molecular BiologyEndocannabinoids (eCBs) influence T-cells. A, structures of non-eCB epoxydocosahexaenoic acid (19,20-DHA-epoxide) and eCBs docosahexaenoy
inflammatory disease February 19,2024
Harnessing good fats to relieve multiple sclerosis symptoms

Harnessing good fats to relieve multiple sclerosis symptoms

by American Society for Biochemistry and Molecular BiologyEndocannabinoids (eCBs) influence T-cells. A, structures of non-eCB epoxydocosahexaenoic acid (19,20-DHA-epoxide) and eCBs docosahexaenoy
inflammatory disease February 19,2024
Multiple sclerosis discovery could end disease's chronic inflammation

Multiple sclerosis discovery could end disease's chronic inflammation

by Josh Barney,University of VirginiaSeparately housed Cd4creAhrfl/flrecover from EAE with increased myelin staining at chronic phase.(A) Clinical score of Cd4creAhrfl/fland Ah
inflammatory disease February 19,2024
Multiple sclerosis discovery could end disease's chronic inflammation

Multiple sclerosis discovery could end disease's chronic inflammation

by Josh Barney,University of VirginiaSeparately housed Cd4creAhrfl/flrecover from EAE with increased myelin staining at chronic phase.(A) Clinical score of Cd4creAhrfl/fland Ah
inflammatory disease February 19,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com